An Open-label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel (E2007) in Subjects With Cervical Dystonia (SAFE-Per CD)

Trial Profile

An Open-label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel (E2007) in Subjects With Cervical Dystonia (SAFE-Per CD)

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 01 Nov 2017

At a glance

  • Drugs Perampanel (Primary)
  • Indications Torticollis
  • Focus Adverse reactions
  • Acronyms SAFE-Per CD
  • Most Recent Events

    • 24 Oct 2017 Planned End Date changed from 1 Sep 2016 to 1 Dec 2018.
    • 24 Oct 2017 Planned primary completion date changed from 1 Jan 2016 to 1 Sep 2018.
    • 24 Oct 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top